Early diagnosis is fundamental for personalized prevention and effective therapeutic management, and in young non-obese individuals carrying MC4R monogenic mutations, an appropriate medical follow-up to prevent or at least delay the onset of obesity [122]. The gene discussed is MC4R; the disease is obesity due to melanocortin 4 receptor deficiency.